NoBACZ Healthcare, a University of Cambridge spinout, secured £4.8 million in funding to advance its innovative 'liquid bandage' technology for treating wounds in livestock and horses.
Target Information
NoBACZ Healthcare is a University of Cambridge spinout dedicated to revolutionizing the treatment of wounds and lesions in horses and livestock through innovative technology. The company has successfully developed a patented 'liquid bandage' that provides an alternative to traditional antibiotic treatments, which often fall short in agricultural settings.
Founded by Dr. Jonathan Powell and Dr. Nuno Faria, NoBACZ emerged from research at the University of Cambridge's Department of Veterinary Medicine. Their initial focus was on addressing digital dermatitis, a painful condition that affects a significant percentage of cows, leading to both animal suffering and financial losses for farmers. This research prompted the team to create a protective solution that outperforms conventional methods.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The livestock sector is a vital part of economy in the UK, Ireland, and Europe, characterized by a growing demand for sustainable and effective animal health solutions. The industry faces numerous challenges, including the rise of ant
Similar Deals
redalpine, IQ Capital Partners, Seedcamp → DaltonTx
2025
The Yield Lab
invested in
NoBACZ Healthcare
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $6M